Search

everythinglearnresearchcommunity

for

Search:↓

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

A blood pressure drug, diltiazem, may also help treat influenza.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Five FDA-approved drugs may help block COVID-19 virus entry.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The medication lopinavir-ritonavir may cause severe hair loss.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Avacopan may cause unexpected side effects, so early monitoring is important.

Some gonadal hormone drugs can block filovirus entry into cells.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Indinavir can cause hair loss and other skin problems.